SCHEMBL4564448

SCHEMBL4564448

Cc1nc(-c2ccccc2)nc(Cl)c1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 1.00
KMT2A Q03164 5/20 0.57
MEN1 O00255 3/20 0.57
HTT P42858 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.52
KCNH2 Q12809 2/20 0.46
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.44
POLB P06746 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
DHPS P49366 1/20 0.42
ALDH1A1 P00352 2/20 0.41
GLA P06280 1/20 0.41
NR1H2 P55055 2/20 0.41
NR1H3 Q13133 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL376122 0.85 LMNA (0.73) LMNAKMT2AMEN1HTTL3MBTL1
SCHEMBL7503985 0.84 LMNA (0.72) LMNAKMT2AMEN1HTTL3MBTL1
SCHEMBL26167674 0.82 LMNA (0.70) LMNAKMT2AMEN1HTTL3MBTL1
SCHEMBL2117995 0.81 LMNA (0.68) LMNAKMT2AMEN1HTTL3MBTL1
SCHEMBL1373850 0.81 LMNA (0.68) LMNAKMT2AMEN1HTTL3MBTL1
SCHEMBL10912364 0.78 LMNA (0.64) LMNAKMT2AMEN1RAB9ANPC1
SCHEMBL7502947 0.78 LMNA (0.64) LMNAKMT2AMEN1HTTL3MBTL1
SCHEMBL18764357 0.78 LMNA (0.64) LMNAKMT2AMEN1HTTL3MBTL1
SCHEMBL5805731 0.77 LMNA (0.62) LMNAKMT2AMEN1HTTL3MBTL1
SCHEMBL10083704 0.76 L3MBTL1 (0.62) LMNAKMT2AMEN1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580857-B2 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy AU JESSIE L-S (US) 2013-11-12 US claimed
US-7625860-B2 Methods and compositions for modulating cell proliferation and cell death AU JESSIE L-S 2009-12-01 US disclosed
US-20040010001-A1 Methods and compositions for modulating cell proliferation and cell death AU JESSIE L-S (US) 2004-01-15 US disclosed